CUV 1.61% $14.68 clinuvel pharmaceuticals limited

Not so fast. Their announcement doesn't mention the FDA denied...

  1. 648 Posts.
    Not so fast. Their announcement doesn't mention the FDA denied them their attempt to skip Phase II and go directly to Phase III.

    Remember, all prior press releases said the company was waiting to hear from the FDA on approval to start a Phase III trial.

    It's better than nothing, but it pushes any US launch back a year.

    Don't read too much into the spin. They aren't mentioning the FDA denied a Phase III start for 2010.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.